114 results on '"Diamond, J.M."'
Search Results
2. The Perioperative Lung Transplant Virome: Torque Teno Viruses Are Elevated in Donor Lungs and Show Divergent Dynamics in Primary Graft Dysfunction
3. Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP
4. Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation
5. Viral Metagenomics Reveal Blooms of Anelloviruses in the Respiratory Tract of Lung Transplant Recipients
6. Should We Reconsider Lung Transplantation Through Uncontrolled Donation After Circulatory Death?
7. Preoperative Plasma Club (Clara) Cell Secretory Protein Levels Are Associated With Primary Graft Dysfunction After Lung Transplantation
8. Donor Age and Early Graft Failure After Lung Transplantation: A Cohort Study
9. Gene Set Enrichment Analysis Identifies Key Innate Immune Pathways in Primary Graft Dysfunction After Lung Transplantation
10. Early Plasma Soluble Receptor for Advanced Glycation End-Product Levels Are Associated With Bronchiolitis Obliterans Syndrome
11. (364) - Quantitative CT Scan Analysis of Healthy Lung Transplant Recipients Correlates with Lung Function in a Multicenter Prospective Cohort
12. Elevated Plasma Clara Cell Secretory Protein Concentration Is Associated with High-Grade Primary Graft Dysfunction
13. (1239) The Impact of Antifibrotic Medications on Lung Transplant Airway Dehiscence, Primary Graft Dysfunction, and 30-Day Survival: A Meta-Analysis
14. The Impact of Induction Immunosuppression Agent on Retransplant-Free and Bronchiolitis Obliterans-Free Survival in Sensitized Lung Transplant Recipients
15. Antiphospholipid Antibodies and Outcomes Following Lung Transplantation
16. Change in Panel Reactive Antibodies in Patients Bridged to Lung Transplantation with Extracorporeal Membrane Oxygenation
17. Validation of a Simple to Use PGD Prediction Algorithm
18. Efficacy and Safety of the Janus Kinase 1 Inhibitor Itacitinib (ITA) in Patients with Bronchiolitis Obliterans (BOS) Syndrome Following Double Lung Transplant
19. Molecular Phenotypes of Frailty in Lung Transplant Candidates
20. Preliminary Development of the Lung Transplant Frailty Index
21. Adipose Gene Expression Profile Changes With Lung Allograft Reperfusion
22. mHealth to Improve Emergent Frailty after Lung Transplantation
23. Lung Transplantation Outcomes after Crossing Low Level Donor Specific Antibodies without Augmented Immunosuppression
24. Predicting PGD after Lung Transplantation
25. Survey of Lung Transplant Community’s Views on Primary Graft Dysfunction
26. The Impact of Antifibrotic Medications on Lung Transplant Airway Dehiscence, Primary Graft Dysfunction, and 30-Day Survival: A Meta-Analysis.
27. Donor-Derived-Cell-Free DNA to Identify Primary Graft Dysfunction Patients at Risk of Chronic Lung Allograft Dysfunction
28. Deep Vein Thrombosis in Extracorporeal Membrane Oxygenation Bridged Lung Transplant Recipients
29. Perspire: Preventing Rehospitalization in Lung Transplant Recipients Utilizing Individualized Rehabilitation Prescriptions
30. The Impact of Elimination of the Donor Service Area (DSA) on United States Lung Transplant Practices and Outcomes at High and Low Competition Centers
31. Obesity Leads to Increased IL-18, Treg Impairment and Increased Risk of PGD
32. Risk Factors for Primary Graft Dysfunction in Patients with Cystic Fibrosis Receiving Lung Transplants
33. (605) - Organ Sequence Number (SN) is Not a Proxy for Organ Quality
34. (480) - Innate Immune Mediator BAL Concentrations and PGD After Lung Transplantation
35. (203) - Human Leukocyte Antigen Allosensitization in Patients Bridged to Lung Transplantation with Extracorporeal Membrane Oxygenation
36. Elevated Plasma Long Pentraxin-3 Levels and Primary Graft Dysfunction After Lung Transplantation for Idiopathic Pulmonary Fibrosis
37. (1282) - Gene Set Enrichment Analysis Identifies a Potential Link Between Smoking and Upregulation of Olfactory Receptor and Cytokine Enrichment Pathways
38. (369) - An In Situ Donor Derived Panel of Innate Immune Transcripts Predicts Primary Graft Dysfunction in Lung Transplant Recipients
39. (689) - Clinical Prediction Model for PGD Among Patients With Pulmonary Hypertension
40. (449) - PGD Is Associated With Persistent Differential Gene Expression After Lung Transplantation
41. (349) - Peripheral Blood Gene Expression Identifies Damage-Associated Innate Immune Pathways in Patients With Primary Graft Dysfunction After Lung Transplantation
42. (17) - Frailty Is Associated With Pre-Operative Delisting and Death in Lung Transplant Candidates
43. (15) - Impact of Diastolic Dysfunction on Primary Graft Dysfunction (PGD) After Lung Transplantation
44. (736) - Ex-Vivo Lung Perfusion Does Not Have a Negative Effect on Transplant Rates at Centers without This Technology in a Single Organ Procurement Organization (OPO)
45. (499) - Plasma Lipid Peroxidation Products Are Higher in Lung Transplant Recipients with PGD and Are Associated with Donor Smoking
46. (369) - Candidate Gene Association Study in BOS
47. Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
48. Plasma Free Hemoglobin Potentiates the Association between Reperfusion FiO2 and Primary Graft Dysfunction after Lung Transplantation
49. Gene Set Enrichment Analysis of Bronchial Alveolar Lavage Fluid Identifies Key Innate Immune Pathways in Primary Graft Dysfunction after Lung Transplantation
50. Plasma PAI-1 Used as a Quantitative Trait Implicates the Innate Immune Regulator TOLLIP in Post Lung Transplant Primary Graft Dysfunction Risk
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.